187 related articles for article (PubMed ID: 23917450)
1. Substantial practice variation exists in the management of childhood nephrotic syndrome.
Samuel S; Morgan CJ; Bitzan M; Mammen C; Dart AB; Manns BJ; Alexander RT; Erickson RL; Grisaru S; Wade AW; Blydt-Hansen T; Feber J; Arora S; Licht C; Zappitelli M
Pediatr Nephrol; 2013 Dec; 28(12):2289-98. PubMed ID: 23917450
[TBL] [Abstract][Full Text] [Related]
2. Practice variations in the management of childhood nephrotic syndrome in the Netherlands.
Schijvens AM; van der Weerd L; van Wijk JAE; Bouts AHM; Keijzer-Veen MG; Dorresteijn EM; Schreuder MF
Eur J Pediatr; 2021 Jun; 180(6):1885-1894. PubMed ID: 33532891
[TBL] [Abstract][Full Text] [Related]
3. Management patterns of childhood-onset nephrotic syndrome.
MacHardy N; Miles PV; Massengill SF; Smoyer WE; Mahan JD; Greenbaum L; Massie S; Yao L; Nagaraj S; Lin JJ; Wigfall D; Trachtman H; Hu Y; Gipson DS
Pediatr Nephrol; 2009 Nov; 24(11):2193-201. PubMed ID: 19672630
[TBL] [Abstract][Full Text] [Related]
4. Practice of Childhood Nephrotic Syndrome Management amongPediatric Nephrologists in the GCC Countries.
Alkandari O; Alshami AA; Alhammadi EA
Saudi J Kidney Dis Transpl; 2021; 32(6):1600-1614. PubMed ID: 35946273
[TBL] [Abstract][Full Text] [Related]
5. Japanese clinical practice patterns of primary nephrotic syndrome 2021: a web-based questionnaire survey of certified nephrologists.
Wada T; Shimizu S; Koizumi M; Sofue T; Nishiwaki H; Sasaki S; Nakaya I; Oe Y; Ishimoto T; Furuichi K; Okada H; Kurita N
Clin Exp Nephrol; 2023 Sep; 27(9):767-775. PubMed ID: 37310570
[TBL] [Abstract][Full Text] [Related]
6. Uncertainty in management of childhood-onset idiopathic nephrotic syndrome: is the long-term prognosis really favorable?
Fujinaga S; Endo A; Ohtomo Y; Ohtsuka Y; Shimizu T
Pediatr Nephrol; 2013 Dec; 28(12):2235-8. PubMed ID: 23832139
[TBL] [Abstract][Full Text] [Related]
7. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[TBL] [Abstract][Full Text] [Related]
8. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
Moorani KN; Hotchandani HM; Zubair AM; Lohana NC; Veerwani NR
BMC Nephrol; 2019 Jul; 20(1):239. PubMed ID: 31269922
[TBL] [Abstract][Full Text] [Related]
10. Variations in actual practice patterns and their deviations from the clinical practice guidelines for nephrotic syndrome in Japan: certified nephrologists' questionnaire survey.
Niihata K; Nishiwaki H; Kurita N; Okada H; Maruyama S; Narita I; Shibagaki Y; Nakaya I
Clin Exp Nephrol; 2019 Nov; 23(11):1288-1297. PubMed ID: 31385161
[TBL] [Abstract][Full Text] [Related]
11. Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.
Webb H; Jaureguiberry G; Dufek S; Tullus K; Bockenhauer D
Pediatr Nephrol; 2016 Apr; 31(4):589-94. PubMed ID: 26525199
[TBL] [Abstract][Full Text] [Related]
12. Rituximab versus cyclophosphamide as first steroid-sparing agent in childhood frequently relapsing and steroid-dependent nephrotic syndrome.
Kari JA; Alhasan KA; Albanna AS; Safdar OY; Shalaby MA; Böckenhauer D; El-Desoky SM
Pediatr Nephrol; 2020 Aug; 35(8):1445-1453. PubMed ID: 32337638
[TBL] [Abstract][Full Text] [Related]
13. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
14. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome.
Trautmann A; Boyer O; Hodson E; Bagga A; Gipson DS; Samuel S; Wetzels J; Alhasan K; Banerjee S; Bhimma R; Bonilla-Felix M; Cano F; Christian M; Hahn D; Kang HG; Nakanishi K; Safouh H; Trachtman H; Xu H; Cook W; Vivarelli M; Haffner D;
Pediatr Nephrol; 2023 Mar; 38(3):877-919. PubMed ID: 36269406
[TBL] [Abstract][Full Text] [Related]
15. Induction prednisone dosing for childhood nephrotic syndrome: how low should we go?
Sibley M; Roshan A; Alshami A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Matsell DG; Mammen C;
Pediatr Nephrol; 2018 Sep; 33(9):1539-1545. PubMed ID: 29789934
[TBL] [Abstract][Full Text] [Related]
16. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.
Trautmann A; Bodria M; Ozaltin F; Gheisari A; Melk A; Azocar M; Anarat A; Caliskan S; Emma F; Gellermann J; Oh J; Baskin E; Ksiazek J; Remuzzi G; Erdogan O; Akman S; Dusek J; Davitaia T; Özkaya O; Papachristou F; Firszt-Adamczyk A; Urasinski T; Testa S; Krmar RT; Hyla-Klekot L; Pasini A; Özcakar ZB; Sallay P; Cakar N; Galanti M; Terzic J; Aoun B; Caldas Afonso A; Szymanik-Grzelak H; Lipska BS; Schnaidt S; Schaefer F;
Clin J Am Soc Nephrol; 2015 Apr; 10(4):592-600. PubMed ID: 25635037
[TBL] [Abstract][Full Text] [Related]
17. The use of steroid-sparing agents in steroid-sensitive nephrotic syndrome.
Abeyagunawardena AS; Dillon MJ; Rees L; van't Hoff W; Trompeter RS
Pediatr Nephrol; 2003 Sep; 18(9):919-24. PubMed ID: 12883981
[TBL] [Abstract][Full Text] [Related]
18. Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
Ravani P; Ponticelli A; Siciliano C; Fornoni A; Magnasco A; Sica F; Bodria M; Caridi G; Wei C; Belingheri M; Ghio L; Merscher-Gomez S; Edefonti A; Pasini A; Montini G; Murtas C; Wang X; Muruve D; Vaglio A; Martorana D; Pani A; Scolari F; Reiser J; Ghiggeri GM
Kidney Int; 2013 Nov; 84(5):1025-33. PubMed ID: 23739238
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
Wang J; Mao J; Chen J; Fu H; Shen H; Zhu X; Liu A; Shu Q; Du L
Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children.
Nickavar A; Safarzadeh AE; Sotoudeh K; Otukesh H; Hooman N
Iran J Kidney Dis; 2012 Sep; 6(5):346-9. PubMed ID: 22976259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
